z-logo
open-access-imgOpen Access
Management of Covid-19 patients with indigenous formulations in home settings- Case reports of two patients
Author(s) -
Neeta Kumar,
Nalini Tripathi,
Mukesh Nandave
Publication year - 2021
Publication title -
international journal of aysuh case reports
Language(s) - English
Resource type - Journals
ISSN - 2457-0443
DOI - 10.52482/ijacare.v5i2.210
Subject(s) - cytokine storm , medicine , covid-19 , siddha , disease , immune system , indigenous , viral load , population , clinical trial , intensive care medicine , virus , immunology , traditional medicine , infectious disease (medical specialty) , biology , ecology , environmental health
This is to report 2 cases experiencing action of indigenous medicine in controlling Covid-19 symptoms in the home setting, without any requirement of hospitalization. Covid-19 (SARS-CoV-2), a viral disease by novel coronavirus, impacted 220 countries. Although, numerous attempts have been made for the management and treatment of Covid-19 with various drugs, traditional Ayurveda and Siddha has been widely reported to be effective in treating viral diseases through altering innate adaptive immune response and inhibition of virus attachment to body cells. It is found to inhibit attachment of virus to human cell, hence reducing viral load induced cytokine storm, inflammatory over reactions in the body of patients and inhibition of community spread. The experience of 2 cases reported here showed how senior citizens with various co-morbidities recovered from covid 19 and remained healthy without sequelae or side effects even after 6 months of follow-up. These observations are vital clues for a large population-based study and ongoing clinical trials. Mechanism of action of Sidha and Ayurvedic medicines like Kabasura Kudineer, Sitopladi, Triphala are well published and highly recommended for affecting viral entry and immune regulatory pathways. With no side effects, secondary infections and action, these regimens pave the ways for safe and effective cure for Covid-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here